|
|
Balance Sheet |
|
Glaxosmithkline Pharmaceuticals Ltd | Industry : Pharmaceuticals - Multinational | Chairman : Renu S Karnad | Home : MNC Asc-Glaxo | Book Value: 91.3566062 | BSE Code : 500660 | Market Cap: 35356.73 | NSE Code : GLAXO | P / E : 55.63 | |
| |
|
|
|
(Rs in Cr.) |
|
|
SOURCES OF FUNDS: | | Share Capital | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 | Reserves & Surplus | 1583.59 | 2508.21 | 1327.71 | 1670.63 | 1973.01 | Total Shareholders Funds | 1753.00 | 2677.62 | 1497.12 | 1840.04 | 2142.42 | Secured Loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Unsecured Loans | 269.76 | 283.08 | 294.92 | 289.57 | 316.30 | Total Debt | 269.76 | 283.08 | 294.92 | 289.57 | 316.30 | Total Liabilities | 2022.76 | 2960.70 | 1792.04 | 2129.61 | 2458.72 | APPLICATION OF FUNDS: | Gross Block | 635.93 | 593.89 | 602.89 | 1454.59 | 561.30 | Less: Accum. Depreciation | 305.99 | 263.26 | 216.00 | 696.53 | 129.69 | Net Block | 329.94 | 330.63 | 386.89 | 758.06 | 431.61 | Capital Work in Progress | 20.31 | 30.50 | 13.21 | 120.12 | 1002.64 | Investments | 542.78 | 390.09 | 24.49 | 24.49 | 24.55 | Inventories | 437.70 | 512.71 | 523.34 | 483.03 | 486.49 | Sundry Debtors | 192.38 | 205.24 | 215.60 | 99.80 | 120.49 | Cash and Bank Balance | 1150.73 | 2479.11 | 1157.68 | 1066.41 | 1155.33 | Loans and Advances | 672.06 | 693.20 | 791.43 | 596.85 | 712.19 | Current Liabilities | 609.14 | 1065.42 | 882.27 | 577.11 | 1229.27 | Provisions | 713.99 | 615.36 | 438.35 | 442.04 | 245.32 | Net Current Assets | 1129.74 | 2209.48 | 1367.43 | 1226.94 | 999.91 | Miscellaneous Expenses not w/o | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Total Assets | 2022.77 | 2960.70 | 1792.02 | 2129.61 | 2458.71 | Contingent Liabilities | 350.59 | 351.10 | 485.78 | 471.42 | 512.80 |
|
|
|
|
|